Relmada Therapeutics, Inc. (RLMD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 3.6800 |
| Open | 3.7600 |
| Bid | 3.8300 x 100 |
| Ask | 3.9000 x 300 |
| Day's range | 3.6600 - 4.0000 |
| 52-week range | 2.3600 - 7.2230 |
| Volume | |
| Avg. volume | 183,121 |
| Market cap | 116.171M |
| Beta (5Y monthly) | 0.19 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2023 Earnings Call Transcript
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2023 Earnings Call Transcript March 19, 2024 Relmada Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.84, expectations were $-0.88. RLMD isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen, and […]
- Thomson Reuters StreetEvents
Q4 2023 Relmada Therapeutics Inc Earnings Call
Q4 2023 Relmada Therapeutics Inc Earnings Call
- GuruFocus.com
Relmada Therapeutics Inc Reports Full-Year and Q4 2023 Financial Results
Progress in CNS Treatments Amid Financial Challenges
© 2024 Yahoo. All rights reserved.